Silo Pharma (SILO) Metrics: History & Chart

Silo Pharma, Inc.(SILO)

Biotechnology · Sarasota, FL

$1.46-0.03 (-2.01%)

Delayed quote: Oct 6, 2026, 3:49 PM EDT

About Silo Pharma, Inc.

Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems. Leading its pipeline is SPC-15, an intranasal treatment engineered to address post-traumatic stress disorder (PTSD) and anxiety disorders stemming from stress. Another key development is SP-26, a time-release, ketamine-loaded implant designed to provide relief for fibromyalgia and chronic pain. Furthermore, Silo Pharma is advancing two preclinical programs: SPC-14, an intranasal compound targeting Alzheimer's disease, and SPU-16, a CNS-homing peptide intended for the management of multiple sclerosis (MS). The company's research and development efforts frequently involve collaborations with prominent academic institutions such as Columbia University and the University of Maryland, Baltimore. Founded in 2010, the company adopted its current name, Silo Pharma, Inc., in September 2020, having previously operated as Uppercut Brands, Inc. Silo Pharma is headquartered in Sarasota, Florida.

Sarasota, FL

3 employees

silopharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Eric Weisblum

View full financials

Third-Party DCF Estimate (FMP)	$6.64
Price Gap vs Third-Party Estimate	+360.67%

7D Total Return	-9.70%
30D Total Return	-37.92%
YTD Total Return	-70.78%
1Y Total Return	-85.76%
3Y Total Return	-93.79%
5Y Total Return	-99.14%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-70.78%
2025	-61.80%
2024	-38.19%
2023	-57.14%
2022	-53.01%
2021	N/A
2020

CAGR TTM	-85.62%
CAGR 3Y	-60.39%
CAGR 5Y	-61.41%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	1.74
PE Ratio Avg TTM	4.04
PE Ratio Avg 3Y	4.04
Current VS TTM Avg	-56.89%
Current VS 3Y Avg	-56.89%
Current VS 5Y Avg	-56.89%

All Metrics

SILO Valuation Metrics

SILO Stock Price Metrics

SILO Dividend Metrics

SILO Growth Rate Metrics

SILO Discounted Cash Flow Metrics

SILO Returns By Period

SILO Yearly Returns

SILO Average Annual Returns By Period (CAGR)

SILO Revenue Metrics

SILO PE Ratio Metrics

SILO PS Ratio Metrics

SILO PB Ratio Metrics

SILO Price to Free Cash Flow Ratio Metrics

SILO Debt to Equity Ratio Metrics

SILO PEG Ratio Metrics

SILO FCF Yield

SILO Earnings Yield

SILO EBITDA Yield

SILO OCF Yield

SILO EV/EBIT Ratio Metrics

SILO EV/EBITDA Ratio Metrics

SILO EV/Assets Ratio Metrics

SILO EV/Sales Ratio Metrics

SILO Current Ratio Metrics

SILO Quick Ratio Metrics

SILO ROIC Metrics

SILO Return on Assets Metrics

SILO Return on Equity Metrics

SILO Net Profit Margin Metrics

SILO Gross Profit Margin Metrics

SILO Tax Rate Metrics

PS Ratio	30.27
PS Ratio Avg TTM	56.56
PS Ratio Avg 3Y	59.56
Current VS TTM Avg	-46.48%
Current VS 3Y Avg	-49.18%
Current VS 5Y Avg	-55.62%

PB Ratio	0.33
PB Ratio Avg TTM	0.73
PB Ratio Avg 3Y	0.74
Current VS TTM Avg	-55.05%
Current VS 3Y Avg	-55.35%
Current VS 5Y Avg	-60.66%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	57.36%
Earnings Yield Avg TTM	25.22%
Earnings Yield Avg 3Y	25.22%
Current VS TTM Avg	+127.42%
Current VS 3Y Avg	+127.42%
Current VS 5Y Avg	+127.42%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.02
Ev/Assets Ratio Avg TTM	0.14
Ev/Assets Ratio Avg 3Y	0.30
Current VS TTM Avg	-85.82%
Current VS 3Y Avg	-93.30%
Current VS 5Y Avg	-94.43%

Ev/Sales Ratio	1.76
Ev/Sales Ratio Avg TTM	13.64
Ev/Sales Ratio Avg 3Y	35.72
Current VS TTM Avg	-87.09%
Current VS 3Y Avg	-95.07%
Current VS 5Y Avg	-96.25%

Current Ratio	5.36
Current Ratio Avg TTM	8.23
Current Ratio Avg 3Y	7.99
Current VS TTM Avg	-34.86%
Current VS 3Y Avg	-32.94%
Current VS 5Y Avg	-63.21%

Quick Ratio	5.36
Quick Ratio Avg TTM	8.23
Quick Ratio Avg 3Y	7.99
Current VS TTM Avg	-34.86%
Current VS 3Y Avg	-32.94%
Current VS 5Y Avg	-63.19%

ROIC	(91.31%)
ROIC Avg 3Y	(72.15%)
ROIC Avg 5Y	(56.91%)
Current VS 3Y Avg	-26.55%
Current VS 5Y Avg	-60.44%
Current VS 10Y Avg	-67.56%

ROA	(75.13%)
ROA Avg TTM	(16.91%)
ROA Avg 3Y	(14.70%)
Current VS TTM Avg	-344.30%
Current VS 3Y Avg	-411.17%
Current VS 5Y Avg	-491.07%

ROE	(91.52%)
ROE Avg TTM	(88.94%)
ROE Avg 3Y	(77.04%)
Current VS TTM Avg	-2.90%
Current VS 3Y Avg	-18.80%
Current VS 5Y Avg	-31.10%

Net Profit Margin	(8269.53%)
Net Profit Margin Avg TTM	(5373.91%)
Net Profit Margin Avg 3Y	(5372.56%)
Current VS TTM Avg	-53.88%
Current VS 3Y Avg	-53.92%
Current VS 5Y Avg	-53.46%

Gross Profit Margin	(1128.89%)
Gross Pft Margin Avg TTM	(262.94%)
Gross Pft Margin Avg 3Y	64.15%
Current VS TTM Avg	-329.33%
Current VS 3Y Avg	-1859.67%
Current VS 5Y Avg	-1328.35%

Tax Rate	0.29%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	(7.53%)
Current VS 3Y Avg	N/A
Current VS 5Y Avg	+103.91%
Current VS 10Y Avg	+108.81%